FRO, PTGX, ARRY Stocks In the News Today

Frontline stock is higher after earnings

May 30, 2017 at 10:15 AM
facebook twitter linkedin

The Dow is trading lower to start the holiday-shortened week on a negative note. Among specific stocks on the move are oil shipping company Frontline Ltd. (NYSE:FRO), as well as drugmakers Protagonist Therapeutics Inc (NASDAQ:PTGX) and Array Biopharma (NASDAQ:ARRY). Here's a quick look at what's moving shares of FRO, PTGX, and ARRY. 

FRO Stock Lower After Earnings

Frontline stock is down 0.9% at $5.57, after the company's first-quarter earnings missed forecasts. This comes after the stock hit an all-time low of $5.48 on Friday. In fact, FRO shares have shed roughly 37% over the past 12 months. Still, Clarksons Platou reiterated its "buy" recommendation -- the only brokerage firm to issue such a rating. The other three analysts tracking Frontline give it just a "hold" rating. 

PTGX Shares Skyrocket on JNJ Deal

Protagonist Therapeutics stock is the best performer on the Nasdaq so far, up 46.8% at $12.07, thanks to news of a collaboration with Johnson & Johnson (NYSE:JNJ) to develop a bowel drug. The shares had been falling fast since topping out above $26 in December, and they're now trading at levels not seen since early April. Meanwhile, short interest on PTGX stock rose by 12.2% in the last two reporting periods, so some bears may be hurting today. 

Bristol-Myers Collaboration Fails to Lift ARRY Stock

Array Biopharma stock is also trading lower, on news the company will collaborate with Bristol-Myers Squibb for a colorectal cancer treatment. ARRY shares were last seen down 1% at $8.08, as they continue to bounce between the $8 and $8.50 levels -- home to their 200-day 50-day moving averages, respectively. ARRY stock has the strong backing of the analyst community, though, with eight of nine brokerages saying it's a "strong buy." 

Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 



Special Offers from Schaeffer's Trading Partners